Warren Buffett's Favorite Stock Is Crushing the S&P 500 in 2025. Here's Why It's Still a Buy.
Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) is a holding company with a number of wholly owned subsidiaries and a $280 billion portfolio of publicly traded stocks and securities. It's also sitting on a whopping $347 billion in cash that can be deployed into new opportunities.
1 Top Energy Stock I Wouldn't Hesitate to Buy in June
We use a lot of energy each and every day to power our modern lives. From the gasoline that fuels our cars to the natural gas that heats our homes to the electricity that runs our devices, we can't function in our modern society without energy. Our need for energy in the country is only growing.
BYD Just Added Another Problem to Tesla's Long List
Tesla ( NASDAQ: TSLA ) investors have been on a bit of a roller coaster ride so far in 2025. The technology company's stock was up early in the year before falling as much as 45% in March and April, and then partially recovering so that it now trades down about 15% for the year.
Reddit Community Reveals Preferred Crypto Casinos with No KYC Requirements: JACKBIT
Recent analysis of cryptocurrency gambling discussions across major Reddit communities reveals significant shifts in user preferences for 2025.
1 Unstoppable Dividend Growth Stock That's Soaring Past the S&P 500
After a tough start to 2025, the S&P 500 index has been rallying in recent weeks, and it is getting back to around all-time highs. Concerns around the economy, tariffs, and trade wars appear to be easing in the markets, as investors remain bullish on the outlook for the future.
Corporate Bitcoin treasuries control over 3% of total BTC supply
More than 60 Bitcoin strategy adopters collectively doubled BTC holdings in the past two months, outstripping the buying speed of Michael Saylor's Strategy.
Pump.fun token rumors mount as protocol revenue drops 71%
Pump.fun has yet to confirm or deny rumors of a $1 billion token sale and 10% airdrop, but the community is split on whether the potential launch would help or harm the crypto space.
Biotech firm touts new AI drug discovery amid third Hong Kong IPO attempt
Biotechnology firm Insilico Medicine said its new drug for lung disease, designed with the help of artificial intelligence (AI), showed positive results in the latest clinical trials, as the company pushes for a public listing in Hong Kong.